O36.011
Maternal care for anti-D [Rh] antibodies, first trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code O36.011 pertains to the specialized medical care provided to pregnant women during their first trimester when they have developed anti-D (Rh) antibodies. These antibodies can pose risks to the developing fetus if not properly managed. The first trimester is a crucial period for screening, diagnosis, and initiation of appropriate interventions to prevent complications related to Rh incompatibility.
Causes & Symptoms
Clinical Causes: Mother is Rh-negative (lacks D antigen on red blood cells) Previous pregnancy with an Rh-positive baby Blood transfusions involving Rh-positive blood Miscarriage or trauma leading to mixing of maternal and fetal blood Certain medical procedures that cause fetal-maternal hemorrhage
Key Symptoms: Usually no symptoms in the mother Possible signs of anemia if fetal complications occur In cases of advanced hemolytic disease, symptoms may include fatigue or jaundice in the fetus (detected through monitoring)
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to determine maternal antibody levels and Rh status. Specifically, the following are used: - Blood typing to establish Rh status - Indirect Coombs test (indirect antiglobulin test) to detect anti-D antibodies in maternal blood - Monitoring antibody titers over time to assess the risk of fetal hemolytic disease - Ultrasound examinations may be utilized to observe fetal health and detect signs of anemia or hydrops fetalis in the fetus
Treatment Protocols: Management strategies focus on preventing hemolytic disease of the fetus and newborn, including: - Administering Rh immunoglobulin (RhIg) to Rh-negative pregnant women to prevent antibody formation, ideally around 28 weeks gestation and within 72 hours postpartum if the baby is Rh-positive - Regular antibody titer testing throughout pregnancy - Close fetal monitoring via ultrasound and possibly Doppler assessments to evaluate fetal well-being - In cases where fetal anemia is detected, intrauterine transfusions may be performed - Postnatal care might include treatments for jaundice or anemia in the newborn It's important to note that early detection and management help ensure better pregnancy outcomes and reduce the risk of complications related to Rh incompatibility.
Clinical Advice & FAQs
Billing Guidance
Is O36.011 a billable ICD-10 code?
Yes, O36.011 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.011?
Clinical documentation must specify the nature of Maternal care for anti-D [Rh] antibodies, first trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference